Johnson & Johnson

Τον Φεβρουάριο αναμένεται η κατάθεση αίτησης της Johnson & Johnson για έγκριση του εμβολίου στην ΕΕ

US firm Johnson & Johnson is likely to apply for EU approval for its Covid-19 vaccine candidate in February, a top lawmaker said on Wednesday.

Clinical data of the vaccine, which Johnson & Johnson is developing through its subsidiary Janssen, have been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.

 The first 10,000 vaccines developed by Pfizer/Biontech will arrive on December 26 in Bulgaria.

On the next day the immunization will begin and the first vaccinated will be medics working on the front line in the fight against COVID 19. This became clear at the briefing of the National Operations Headquarters.

Documents related to the Pfizer coronavirus vaccine were illegally accessed during a cyberattack at the EU regulator, the company said on Dec. 9, as Germany and other northern hemisphere countries grappled with a winter surge in the pandemic.

Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19 as well as to donate to lower and middle income countries or re-direct to other European countries.

The European Commission has concluded exploratory talks with Johnson & Johnson to buy 200 million doses of a potential COVID-19 vaccine, the EU executive and the U.S. pharmaceutical company said on Thursday.

A Greek court has convicted 13 people in connection with alleged corruption during state hospital purchases from DePuy, a subsidiary of US healthcare giant Johnson & Johnson.
The Athens criminal court on Tuesday acquitted another seven people over the same case, in which Greek hospital doctors allegedly took bribes to prescribe DePuy orthopedic products.

US pharmaceutical giant Johnson & Johnson was Thursday ordered to pay out $4.69 billion in damages in a lawsuit representing 22 women and their families who alleged a talc sold by the company contained asbestos and caused them to suffer cancer.

Human testing of a new experimental HIV vaccine has been launched in southern Africa, the first time in more than a decade that two big HIV vaccine efficacy trials are being carried out concurrently.

With everybody being upset about the possibility that the US President Donald Trump will withdraw the USA from the Paris Accord, we present you here what Trump side’s arguments are: